NOLA (NeuWave Observational Liver Ablation) Registry
Part of paid clinical trials in Loma Linda, California.
- Sponsor
- Ethicon, Inc.
- Study ID
- NCT04107766
- Status
- Terminated
Conditions
- Cancer of the Liver
- Liver Cancer
- Neoplasms, Liver
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Microwave Ablation — DEVICEPatients who meet the eligibility criteria will undergo microwave ablation (MWA) with the NEUWAVE Microwave Ablation System with or without Ablation Confirmation of at least one soft-tissue liver lesion, in accordance with the study site's standard-of-care (SOC) practices.
Study Details
This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
Key Dates
- Start date
- Jan 15, 2020
- Status verified
- Apr 2026
- Primary completion
- Jun 18, 2025
- Completion
- Jun 18, 2025
Study Design
- Enrollment
- 1,254 participants (actual)
Arms
- Arm: PopulationPatients with at least one soft-tissue liver lesion ablated with the NEUWAVE Microwave Ablation System or NEUWAVE Microwave Ablation System with Ablation Confirmation.
Primary Outcome Measure
Number of Patients Whose Ablation Resulted in Technical Success [ Time Frame: Immediately post-ablation (Day 0) ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loma Linda University Medical Center | Loma Linda | California | 92354 | - |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | - |
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095 | - |
| Sutter Institute for Medical Research | Sacramento | California | 95816 | - |
| Olive View UCLA | Sylmar | California | 91342 | - |
| Mayo Clinic | Jacksonville | Florida | 32224 | - |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | - |
| ICAHN School of Medicine at Mount Sinai | New York | New York | 10029 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | - |
| MD Anderson Cancer Center | Houston | Texas | 77030 | - |
| University of Virginia | Charlottesville | Virginia | 22908 | - |
| University of Washington Medical Center | Seattle | Washington | 98101 | - |
| University of Wisconsin At Madison | Madison | Wisconsin | 53792 | - |
Find similar trials in Loma Linda, CA
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaPHASE2 · Recruiting · Allison O'Neill, MD · San Francisco, California
- ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaPHASE1/PHASE2 · Recruiting · Eureka Therapeutics Inc. · San Francisco, California